Form 4: Medpace Director Converts RSUs to Common Stock

Medpace Holdings Director Brian T. Carley converted 62 restricted stock units into common stock on December 31, 2025, increasing his direct beneficial ownership to 26,281 shares.

Summary

• Brian T. Carley, a Director of Medpace Holdings, Inc. (MEDP), reported a change in his beneficial ownership.
• On December 31, 2025, Mr. Carley acquired 62 shares of Medpace common stock through the exercise of restricted stock units (RSUs).
• These 62 RSUs were part of a larger grant of 249 units made on November 29, 2024, which fully vested on December 31, 2025.
• Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
• Following this transaction, Mr. Carley directly beneficially owns 26,281 shares of Medpace Holdings, Inc. common stock.

Sentiment

Score: 6

Explanation: Slightly positive as a director increased their direct beneficial ownership through a routine equity compensation conversion, aligning interests with shareholders. The transaction itself is not significant enough to warrant a high score.

Positives

• Increased direct beneficial ownership by a company director, which generally aligns management's interests more closely with those of shareholders.
• The transaction represents a routine vesting and conversion of previously granted equity compensation, indicating standard compensation practices.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This routine insider transaction reflects standard equity compensation practices for directors in publicly traded companies, particularly within the contract research organization (CRO) or healthcare services industry. It does not provide specific insights into broader industry trends or the competitive landscape.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by a director can be viewed positively as it further aligns management's interests with those of shareholders.

Key Dates

Keywords

Medpace Holdings, MEDP, Brian T. Carley, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Beneficial Ownership, Equity Compensation